Serum periostin is not related to asthma predictive index
Main Article Content
Keywords
Asthma, Asthma predictive index, Periostin, Pre-school, Recurrent wheezing
Abstract
Background: In contrast to adult asthmatic patients, studies on the role of serum periostin levels in schoolchildren with asthma are still conflictive, and very few studies have been performed in pre-schoolers. The aim of this study was to compare serum periostin levels in recurrent wheezer pre-schoolers according to their asthma predictive index (API) condition.
Methods: We performed a case-control study enrolling pre-schoolers with recurrent wheezing episodes (>3 episodes confirmed by physician) presented at one paediatric clinic in Santiago, Chile. The population was divided according to stringent API criteria into positive or negative.
Results: In a one-year period, 60 pre-schoolers were enrolled. After excluding 12 (due to not fulfilment of inclusion criteria or refusal of blood sample extraction), 48 remaining pre-schoolers (27 males, age range from 24 to 71 months) completed the study; 34 were API positive and 14 were API negative. There were no significant differences in demographics between groups. The level of serum periostin levels for pre-schoolers with positive API and negative API were (median 46.7 [25.5-83.1] and 67.5 [20.5-131.8], p = 0.9, respectively). The area under the curve for the serum periostin levels for predict positive API was 0.5, 95% CI [0.29-0.70], p = 0.9. No significant correlation between serum periostin levels and peripheral blood eosinophils was found.
Conclusion: Serum periostin levels were no significantly different between wheezer preschoolers with positive and negative API. More studies are needed to confirm this finding.
References
2. Guilbert TW, Mauger DT, Lemanske RF Jr. Childhood asthma-predictive phenotype. J Allergy Clin Immunol Pract. 2014;2:664-70.
3. Luo G, Nkoy FL, Stone BL, Schmick D, Johnson MD. A systematic review of predictive models for asthma development in children. BMC Med Inform Decis Mak. 2015;15:99.
4. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000;162 Pt 1:1403-6.
5. Toll DB, Janssen KJ, Vergouwe Y, Moons KG. Validation, updating and impact of clinical prediction rules: a review. J Clin Epidemiol. 2008;61:1085-94.
6. Caudri D, Wijga A, Schipper ACM, Hoekstra M, Postma DS, Koppelman GH. Predicting the long-term prognosis of children with symptoms suggestive of asthma at preschool age. J Allergy Clin Immunol. 2009;124, 903-910.e1-7.
7. Leonardi NA, Spycher BD, Strippoli MP, Frey U, Silverman M, Kuehni CE. Validation of the asthma predictive index and comparison with simpler clinical prediction rules. J Allergy Clin Immunol. 2011;127, 1466-1472.e6.
8. Rodriguez-Martinez CE, Sossa-Briceno MP, Castro-Rodriguez JA. Discriminative properties of two predictive indices for asthma diagnosis in a sample of preschoolers with recurrent wheezing. Pediatr Pulmonol. 2011;46:1175-81.
9. Balinotti JE, Colom A, Kofman C, Teper A. Association between the asthma predictive index and levels of exhaled nitric oxide in infants and toddlers with recurrent wheezing. Arch Argent Pediatr. 2013;111:191-5.
10. Berankova K, Uhlik J, Honkova L, Pohunek P. Structural changes in the bronchial mucosa of young children at risk of developing asthma. Pediatr Allergy Immunol. 2014;25:136-42.
11. Castro-Rodriguez JA, Sardón O, Pérez-Yarza EG, Korta J, Aldasoro A, Corcuera P. Young infants with recurrent wheezing and positive asthma predictive index have higher levels of exhaled nitric oxide. J Asthma. 2013;50:162-5.
12. Keklikian E, Sanchez-Solis M, Bonina AJ, Meneguzzi A, PastorVivero MD, Mondejar-Lopez P. Do risk factors for persistent asthma modify lung function in infants and young children with recurrent wheeze? Pediatr Pulmonol. 2010;45:914-8.
13. Brand PL, Luz Garcia-Garcia M, Morison A, Vermeulen JH, Weber HC. Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. Respir Med. 2011;105:1588-95.
14. Li YQ, Xue HY, Chen W, Cao LF. [Application of asthma predictive index-based group therapy in wheezing children under 5 years of age]. Zhongguo Dang Dai Er Ke Za Zhi. 2014;16:795-9.
15. Expert Panel, National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma; 2017 [updated 2008]. Available from: www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm [Accessed March 2017].
16. Global Initiative for Asthma. Global strategy for asthma management and prevention; 2017. Available from: www.ginasthma.org [accessed March 2017].
17. Castro-Rodriguez JA. The necessity of having asthma predictive scores in children. J Allergy Clin Immunol. 2013;132:1311-3.
18. Stoltz DJ, Jackson DJ, Evans MD, Gangnon RE, Tisler CJ, Gern JE, et al. Specific patterns of allergic sensitization in early childhood and asthma & rhinitis risk. Clin Exp Allergy. 2013;43:233-41.
19. Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med. 2013;368:2455-66.
20. Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicenter, double-blind, placebo-controlled trial. Lancet. 2012;380:651-9.
21. Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011;365:1088-98.
22. Lopez-Guisa JM, Powers C, File D, Cochrane E, Jimenez N, Debley JS. Airway epithelial cells from asthmatic children differentially express proremodeling factors. J Allergy Clin Immunol. 2012;129:990-7.
23. Jia G, Erickson RW, Choy DF, Mosesova S, Wu LC, Solberg OD, et al., Bronchoscopic Exploratory Research Study of Biomarkers in Corticosteroid-refractory Asthma (BOBCAT) Study Group. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol. 2012;130:647-54.
24. Song JS, You JS, Jeong SI, Yang S, Hwang IT, Im YG, et al. Serum periostin levels correlate with airway hyper-responsiveness to methacholine and mannitol in children with asthma. Allergy. 2015;70:674-81.
25. Konradsen JR, Skantz E, Nordlund B, Lidegran M, James A, Ono J, et al. Predicting asthma morbidity in children using proposed
markers of Th2-type inflammation. Pediatr Allergy Immunol. 2015;26:772-9.
26. Anderson HM, Lemanske RF Jr, Arron JR, Holweg CT, Rajamanickam V, Gangnon RE, et al. Relationships among aeroallergen sensitization, peripheral blood eosinophils, and periostin in pediatric asthma development. J Allergy Clin Immunol. 2017;139:790-6.
27. Inoue T, Akashi K, Watanabe M, Ikeda Y, Ashizuka S, Motoki T, et al. Periostin as a biomarker for the diagnosis of pediatric asthma. Pediatr Allergy Immunol. 2016;27:521-6.
28. Inoue Y, Izuhara K, Ohta S, Ono J, Shimojo N. No increase in the serum periostin level is detected in elementary school-age children with allergic diseases. Allergol Int. 2015;64: 289-90.
29. Kim DY, Kim JH, Lee KH, Hong SC, Lee HS, Kang JW. Serum periostin level is not associated with allergic rhinitis or allergic sensitization in Korean children. Int J Pediatr Otorhinolaryngol. 2017;93:24-9.
30. Matsusaka M, Kabata H, Fukunaga K, Suzuki Y, Masaki K, Mochimaru T, et al. Phenotype of asthma-related with high serum periostin levels. Allergol Int. 2015;64:175-80.
31. Kim MA, Izuhara K, Ohta S, Ono J, Yoon MK, Ban GY, et al. Association of serum periostin with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2014;113: 314-20.
32. Kanemitsu Y, Ito I, Niimi A, Izuhara K, Ohta S, Ono J, et al. Osteopontin and periostin are associated with a 20-year decline of pulmonary function in patients with asthma. Am J Respir Crit Care Med. 2014;190:472-4.
33. Habernau Mena A, Del Pozo Abejón V, Rodríguez Vidigal FF, Bobadilla González P. Role of periostin in uncontrolled asthma in children (DADO study). J Investig Allergol Clin Immunol. 2017;27, http://dx.doi.org/10.18176/jiaci.0144.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.